STAT+: Trump’s Medicare director seeks to rein in expectations for TrumpRx
The Trump administration is counting on its drug pricing efforts to help with the midterm elections.
Alleged Inaction Over Ozempic Misuse for Weight Loss, Delhi HC Seeks Govt, CDSCO Response
New Delhi: The Delhi High Court on Tuesday called for responses from the government, the Central Drugs Standard Control Organisation (CDSCO), and other concerned authorities regarding a contempt petition that…
Dr Reddy’s Slapped Rs 2.19 Crore GST Demand for FY20-22, Plans to Challenge Orders
Hyderabad: Dr. Reddy's Laboratories Limited has received three separate tax demand orders from the Goods and Services Tax (GST) authority for the financial years 2019-20 to 2021-22, the company informed…
USFDA Flags Aurobindo’s Eugia Unit-II with OAI Status After Bhiwadi Inspection
Hyderabad: Aurobindo Pharma Limited has recently informed that the United States Food and Drug Administration (USFDA) has classified Unit-II of its wholly owned subsidiary, Eugia Pharma Specialities Limited, as "Official…
Fake Drug Inspector Arrested in Jaipur for Extorting Chemists, Running Job Scam
Jaipur: Police in Jaipur have arrested a man accused of deceiving several people by impersonating government officials, including a drug inspector and a secretariat officer. The accused allegedly used these…
Johnson and Johnson Gets USFDA Nod for Oral Psoriasis Drug Icotyde
Bengaluru: The U.S. Food and Drug Administration has ​approved Johnson & Johnson's oral pill ​for psoriasis, the company said on Wednesday, ​paving the way for a more convenient treatment option…
USFDA Pushes Shift from Animal Testing, Draft Guidance Backs AI and Human-Based Drug Research
Bengaluru: The U.S. Food and Drug Administration on Wednesday issued a draft ​guidance to help companies reduce animal ​studies of experimental drugs and adopt newer methods, such as ​computer simulations…
Stopping GLP-1 drugs can quickly erase cardiovascular benefits, suggests study
Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which…
STAT+: Novo Nordisk’s high-dose Wegovy approved in the U.S.
A high-dose version of Novo Nordisk’s injectable obesity drug Wegovy received U.S. approval.
Health Economics and “Delivering Dollars to the American People”
Healthcare policy is back on voters’ minds. The Republican party has placed its bet on consumer-driven healthcare, framed as “delivering dollars to the American people”, as a winning strategy. While…